Skip to content

EPISODE II: Prevention of relapse following early psychosis

EPISODE II: Prevention of relapse following early psychosis using combined family and individual CBT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000514606
Acronym
Episode II
Enrollment
120
Registered
2005-09-26
Start date
2003-10-29
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

This study aims to evaluate via a randomized controlled trial a combined individual and family-based psychosocial intervention aimed at relapse prevention following remission from first-episode psychosis in young people aged 15-25 years compared with treatment as usual in a first episode psychosis service.

Sponsors

Eli Lily
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
15 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

(1) Eligible for EPPIC services (DSM-IV diagnosis of a psychotic disorder or mood disorder with psychotic features, no more than 6 months of prior treatment with an antipsychotic prior to registration with EPPIC) and Barwon Heath First Episode Psychosis Service (see EPPIC criteria above), with a maximum of 12 months of treatment received within the service; (2) Able to converse in English without an interpreter; and (3) Have reached complete, or near-complete remission of positive psychotic sypmtoms for a 1-month period, determined by scores on the expanded BPRS (Overall & Gorham, 1962) of 3 or less on the items hallucinations, conceptual disorganization, suspiciousness and unusual thought content.

Exclusion criteria

(1) Unable to converse in, or read English without an interpreter; (2)Severe intellectual disability; (3)Persistent positive psychotic symptoms; and (4) Psychotic disorder due to a medical condition.

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 3, 2026